Cerity Partners
IDXX icon

Cerity Partners’s Idexx Laboratories IDXX Stock Holding History

Cerity Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.1M Sell
17,284
-3,107
-15% -$1.74M 0.01% 818
2026
Q1 		$11.5M Sell
20,391
-2,314
-10% -$1.48M 0.02% 628
2025
Q4 		$15.4M Buy
22,705
+1,410
+7% +$960K 0.02% 488
2025
Q3 		$13.6M Buy
21,295
+125
+0.6% +$75.9K 0.02% 475
2025
Q2 		$11.4M Buy
21,170
+2,540
+14% +$1.21M 0.02% 494
2025
Q1 		$7.82M Buy
18,630
+7,235
+63% +$3.14M 0.02% 577
2024
Q4 		$5.07M Buy
11,395
+471
+4% +$207K 0.01% 708
2024
Q3 		$5.52M Buy
10,924
+2,202
+25% +$1.07M 0.01% 663
2024
Q2 		$4.25M Sell
8,722
-4,379
-33% -$2.2M 0.01% 654
2024
Q1 		$7.07M Buy
13,101
+6,641
+103% +$3.63M 0.02% 555
2023
Q4 		$3.59M Buy
6,460
+1,409
+28% +$661K 0.01% 614
2023
Q3 		$2.21M Sell
5,051
-4,340
-46% -$2.16M 0.01% 563
2023
Q2 		$4.72M Buy
9,391
+837
+10% +$401K 0.02% 510
2023
Q1 		$5.09M Buy
8,554
+752
+10% +$360K 0.01% 495
2022
Q4 		$3.18M Buy
7,802
+4,904
+169% +$1.9M 0.02% 448
2022
Q3 		$944K Sell
2,898
-125
-4% -$45.9K 0.01% 531
2022
Q2 		$1.06M Buy
3,023
+1,591
+111% +$649K 0.01% 536
2022
Q1 		$386K Buy
1,432
+697
+95% +$367K 0.01% 655
2021
Q4 		$488K Buy
+735
New +$461K 0.01% 604
2021
Q3 		– Sell
-606
Closed -$383K – 704
2021
Q2 		$383K Sell
606
-55
-8% -$30.4K 0.01% 518
2021
Q1 		$323K Buy
+661
New +$331K 0.01% 535
2019
Q2 		– Sell
-1,075
Closed -$240K – 532
2019
Q1 		$240K Buy
+1,075
New +$222K 0.02% 460
2018
Q4 		– Sell
-944
Closed -$236K – 531
2018
Q3 		$236K Buy
+944
New +$229K 0.02% 479

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Cerity Partners's IDXX Position: Q2 2026 in Review

Cerity Partners reduced its Idexx Laboratories (IDXX) stake by 15% in Q2 2026, selling an estimated $1.74M and leaving 17,284 shares worth $9.1M. The position accounts for 0.01% of the portfolio, ranked #818.

Cerity Partners first reported a position in IDXX in Q3 2018 and has held it in 23 quarters since. The position peaked at $15.4M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Cerity Partners held 17,284 shares of Idexx Laboratories worth $9.1M as of Q2 2026.
  • Cerity Partners sold 3,107 Idexx Laboratories shares in Q2 2026, an estimated $1.74M.
  • Idexx Laboratories made up 0.01% of Cerity Partners's portfolio in Q2 2026, its #818 holding.
  • Cerity Partners first reported a position in Idexx Laboratories in Q3 2018 and has held it in 23 quarters since.
  • Cerity Partners's Idexx Laboratories position peaked at $15.4M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.